Answers are grounded in this paper and cite their sources.
Purpose: Radiation-induced primary hypothyroidism is a common yet under-recognized toxicity after radiotherapy for undifferentiated nasopharyngeal carcinoma (UNPC). This study evaluated clinical and dosimetric predictors of hypothyroidism following intensity modulated radiotherapy (IMRT). Methods: We retrospectively analyzed 50 non-metastatic (M0) UNPC patients treated with IMRT at the Salah Azaiez Institute (2016–2019), with regular thyroid function follow-up (12–60 months). Dosimetric parameters were reviewed for associations with thyroid dysfunction. Results: Hypothyroidism developed in 66% of patients (median onset: 26 months). Its risk was increased with a mean thyroid dose ≥56.67 Gy. Sparing less than 9.9 cc of thyroid tissue from 60 Gy (VS60) strongly predicted hypothyroidism (AUC 0.952, 95% CI 0.886–1; sensitivity 93.9%; specificity 100%). Affected patients had smaller thyroid glands (14.73 ± 6.14 vs. 19.17 ± 7.07cc; p = 0.026) and higher mean thyroid doses (59.8 ± 4.27 vs. 55.19 ± 3.41Gy; p < 0.001). Female sex ( p = 0.035), higher T stage ( p = 0.007), and nodal involvement ≥N2 ( p = 0.003) were also significant predictors. Conclusions: Radiation-induced hypothyroidism is a frequent, dose-dependent toxicity in UNPC. Preserving ≥9.9 cc of thyroid tissue below 60 Gy may reduce risk. Prospective validation is needed to confirm reliable dose thresholds.
No takes yet. Share an insight, caveat, or question.
Kouti et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: